← FDA Drug Approvals (Drugs@FDA)
CISPLATIN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ACCORD HLTHCARE · Approved 2015-08-18
Drug application
- FDA Application #
ANDA206774- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- CISPLATIN
- Generic name
- CISPLATIN
- Active ingredients
- CISPLATIN
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- ACCORD HLTHCARE
- Manufacturer
- BluePoint Laboratories
- First approval
- 2015-08-18
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown